Kidney damage associated with COVID-19: from the acute to the chronic phase

Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection is well established as a systemic disease including kidney damage. The entry point into the renal cell remains the angiotensin-converting enzyme 2 (ACE-2) receptor and the spectrum of renal lesions is broad, with a clear predomin...

Full description

Saved in:
Bibliographic Details
Main Authors: Yannick Mayamba Nlandu, Elliot Koranteng Tannor, Titilope Adetoun Bamikefa, Jean-Robert Rissassi Makulo
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2316885
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591103709151232
author Yannick Mayamba Nlandu
Elliot Koranteng Tannor
Titilope Adetoun Bamikefa
Jean-Robert Rissassi Makulo
author_facet Yannick Mayamba Nlandu
Elliot Koranteng Tannor
Titilope Adetoun Bamikefa
Jean-Robert Rissassi Makulo
author_sort Yannick Mayamba Nlandu
collection DOAJ
description Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection is well established as a systemic disease including kidney damage. The entry point into the renal cell remains the angiotensin-converting enzyme 2 (ACE-2) receptor and the spectrum of renal lesions is broad, with a clear predominance of structural and functional tubular lesions. The most common form of glomerular injury is collapsing glomerulopathy (CG), which is strongly associated with apolipoprotein L1(APOL-1) risk variants. These acute lesions, which are secondary to the direct or indirect effects of SARS-CoV-2, can progress to chronicity and are specific to long COVID-19 in the absence of any other cause. Residual inflammation associated with SARS-CoV-2 infection, in addition to acute kidney injury (AKI) as a transitional state with or without severe histological lesions, may be responsible for greater kidney function decline in mild-to-moderate COVID-19. This review discusses the evidence for renal histological markers of chronicity in COVID-19 patients and triggers of low-grade inflammation that may explain the decline in kidney function in the post-COVID-19 period.
format Article
id doaj-art-7317081d72f04341b2e06e544242a655
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-7317081d72f04341b2e06e544242a6552025-01-23T04:17:48ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2316885Kidney damage associated with COVID-19: from the acute to the chronic phaseYannick Mayamba Nlandu0Elliot Koranteng Tannor1Titilope Adetoun Bamikefa2Jean-Robert Rissassi Makulo3Nephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the CongoDepartment of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, GhanaRenal Unit, Uniosun Teaching Hospital Osogbo, Osun State University, Osogbo, Osun State, NigeriaNephrology Unit, Kinshasa University Hospital, Kinshasa, Democratic Republic of the CongoSevere acute respiratory syndrome coronavirus-2 (SARS-COV-2) infection is well established as a systemic disease including kidney damage. The entry point into the renal cell remains the angiotensin-converting enzyme 2 (ACE-2) receptor and the spectrum of renal lesions is broad, with a clear predominance of structural and functional tubular lesions. The most common form of glomerular injury is collapsing glomerulopathy (CG), which is strongly associated with apolipoprotein L1(APOL-1) risk variants. These acute lesions, which are secondary to the direct or indirect effects of SARS-CoV-2, can progress to chronicity and are specific to long COVID-19 in the absence of any other cause. Residual inflammation associated with SARS-CoV-2 infection, in addition to acute kidney injury (AKI) as a transitional state with or without severe histological lesions, may be responsible for greater kidney function decline in mild-to-moderate COVID-19. This review discusses the evidence for renal histological markers of chronicity in COVID-19 patients and triggers of low-grade inflammation that may explain the decline in kidney function in the post-COVID-19 period.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2316885Kidney damageCOVID-19chronic kidney diseaseacute kidney injurySARS-CoV-2
spellingShingle Yannick Mayamba Nlandu
Elliot Koranteng Tannor
Titilope Adetoun Bamikefa
Jean-Robert Rissassi Makulo
Kidney damage associated with COVID-19: from the acute to the chronic phase
Renal Failure
Kidney damage
COVID-19
chronic kidney disease
acute kidney injury
SARS-CoV-2
title Kidney damage associated with COVID-19: from the acute to the chronic phase
title_full Kidney damage associated with COVID-19: from the acute to the chronic phase
title_fullStr Kidney damage associated with COVID-19: from the acute to the chronic phase
title_full_unstemmed Kidney damage associated with COVID-19: from the acute to the chronic phase
title_short Kidney damage associated with COVID-19: from the acute to the chronic phase
title_sort kidney damage associated with covid 19 from the acute to the chronic phase
topic Kidney damage
COVID-19
chronic kidney disease
acute kidney injury
SARS-CoV-2
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2316885
work_keys_str_mv AT yannickmayambanlandu kidneydamageassociatedwithcovid19fromtheacutetothechronicphase
AT elliotkorantengtannor kidneydamageassociatedwithcovid19fromtheacutetothechronicphase
AT titilopeadetounbamikefa kidneydamageassociatedwithcovid19fromtheacutetothechronicphase
AT jeanrobertrissassimakulo kidneydamageassociatedwithcovid19fromtheacutetothechronicphase